NCT04931225View on ClinicalTrials.gov

LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)

PHASE3RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Septic Shock
Interventions
DRUG

Landiolol

Intravenous Landiolol injection (from 0.5 to 10 µg/kg/min during 12 hours) up to a 15% decrease in HR on microcirculatory vascular reactivity.

Trial Locations (1)

75012

RECRUITING

Intensive care department, Hôpital Saint Antoine, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER